drugset / Press release
Galderma receives Positive Opinion through European Decentralised Procedure for Approval of EPIDUO® 0.3% / 2.5% gel for Acne Patient
2016-09-27 · Galderma R&D · original galderma.com ↗
Lausanne, 27 July 2016 - Galderma, Nestlé Skin Health’s medical solutions business, announced that it has received a Positive Opinion from 16 concerned European regulatory agencies for the market approval of EPIDUO 0.3% / 2.5% gel (adapalene/ benzoyl peroxide), for the cutaneous treatment of acne vulgaris, when comedones, numerous papules and pustules are present. Read the full story on Galderma.com
The release as fetched from its publisher. galderma.com ↗